Proteomics Market is expected to grow at CAGR of 29.20% to extend a value of USD 380.7 Billion by 2034

Proteomics is the study of structure and function of proteins in which way they work and interact inside cells with each other. Proteomics provides structure and function of organism with better understanding. Proteomics are used for investigating expression of proteins, modification of proteins, rate of protein production, steady sate abundance, degradation, etc. Blast, Delta Mass, ChemClac, Comet, and Entrez are main tools of proteomics. Rising prevalence of cancer diseases has driven the market growth because proteomics are used for identifying characteristics of drug-resistant cancer cells, and it discovers the targets that overcome drug resistance which develops during anti-cancer treatment. Proteomics based technology assess tumor prognosis, tumor classification, prediction, and helps in identifying potential responders for specific therapies. Proteomics are used in medicine, drug discovery because it help in identifying and monitoring biomarkers by analyzing proteins in body fluids like serum, urine, spinal fluid, and exhaled breath. Proteomics help in facilitating drug development by providing comprehensive map of interaction of proteins which are associated with disease pathways. Factors such as application of proteomics in the diagnosis of infectious diseases, technological advancement, increase in health care expenditure, rise in awareness, etc. are the other factors likely to drive the market growth. However, wide applications and rising prevalence of cancer diseases has given positive impact on Proteomics market growth.Proteomics Market was valued at US$ 37.0 Billion in 2024 and is projected to grow at a CAGR of 29.20% to reach US$ 380.7 Billion by 2034.

The report “Proteomics Market, By Technology (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, and Others), By Software & Services (Bioinformatics Software & Services, and Core Proteomics Services), By Application (Clinical Diagnostics, Drug Discovery, and Others), By End-Users (Hospitals, Laboratories, and Others), By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Highlights:

• In January 2022, Seer has launched next-generation proteomics research platform for categorizing tens of thousands of proteins in human body which drives the biologic functions of life and disease. The Proteograph product suite is relied on various range of magnetic nanoparticles in which each one is engineered to tag themselves for variety of proteins for preparing them for screening by mass spectrometry. With new launch Seer has also partnered with Biopharma Service providers to form centers of excellence program which includes, Discovery Life Sciences, Biodesix, Sanford Burnham Prebys Medical Discovery Institute and Soulbrain for driving the adoption of company’s proteomics research.
• In March 2022, Biognosys has launched new expanded suite of Proteomics platform for supporting Drug Research & Development. It offers three platforms – TrueTarget, TrueDiscovery and TrueSignature which provides an integrated suite of research services which reveal deep biological insights across entire research & development pipeline from early stage discovery to clinic.
• In December 2022, Discovery Life Sciences has launched world-class Proteomic Services Division which is supported by leading technology partners. This division offers exploratory & targeted proteomics by using SCIEX LC-MS/MS, Seer Proteograph Product suite, Luminex xMAP platforms, and Proximity Extension Assay (PEA). The new Proteomic Services Division is accepting samples from biotech, pharmaceutical, non-profit, government, and academic research centers.

Analyst View:

The key factor driving the growth of the Proteomics market is rising demand for personalized medicine, rising prevalence of cancer disease, etc. Proteomics technology is used extensively in molecular medicine for discovery of biomarker. Proteomics help in identifying invaluable disease-specific biomarkers by analyzing global protein profiling in body fluids. Proteomics help researchers to detect more protein targets than genomics which result in highly effective clinical trials & biomarker studies. Proteomics are used in early diagnosis of disease and help in monitoring of disease development. Proteomics has wide variety of applications which includes, identification of biomarkers, diagnosis of disease, drug discovery, antibody profiling, diabetes research, nutrition research, urological cancer research, and others. However, rising prevalence of cancer diseases and wide applications of proteomics is expected to boosts the demand for target market growth. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Proteomics Market, By Technology (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, and Others), By Software & Services (Bioinformatics Software & Services, and Core Proteomics Services), By Application (Clinical Diagnostics, Drug Discovery, and Others), By End-Users (Hospitals, Laboratories, and Others), By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Market Insights from the report:

Proteomics Market accounted for US$ 37.0 billion in 2024 and is estimated to be US$ 380.7 billion by 2034 and is anticipated to register a CAGR of 29.20%. The Proteomics Market is segmented based on Technology, Software & Services, Application, End-Users and Region.

• Based on Technology, Proteomics Market is segmented into Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, and others.
• Based on Software & Services, Proteomics Market is segmented into Bioinformatics Software & Services, and Core Proteomics Services.
• Based on Application, Proteomics Market is segmented into Clinical Diagnostics, Drug Discovery, and others.
• Based on End-Users, Proteomics Market is segmented into Hospitals, Laboratories, and others.
• By Region, the Proteomics Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Proteomics Market:

The prominent players operating in the Proteomics  Market includes, Thermo Fisher Scientific, Inc., Agilent Technologies Inc., GE Healthcare, Bio-Rad Laboratories Inc., Danaher Corporation, Merck KGaA, Luminex Corporation, Bruker Corporation, Waters Corporation, PerkinElmer, Inc., and others.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

 

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com